Caribou Biosciences's total assets for Q2 2025 were $220.90M, a decrease of -19.28% from the previous quarter. CRBU total liabilities were $54.77M for the fiscal quarter, a -2.95% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.